VYLOY
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
0469-3425 -
Package NDC
0469-3425-10 -
Application number
BLA761365 -
SPL ID
869b812d-b22d-49ed-9d86-c30e4a014a9d -
SPL set ID
e7695a21-abb6-47ac-93f8-0ece5a9c4409 -
UNII
TF5MPQ8WGY -
RxCUI
2695876 -
RxCUI
2695882 -
RxCUI
2710430 -
RxCUI
2710432
What the source publishes
- Labeler
- Astellas Pharma US, Inc.
- Active ingredients
- ZOLBETUXIMAB
- Form
- INJECTION, POWDER, FOR SUSPENSION
- Routes
- INTRAVENOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- BLA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "VYLOY",
"splId": "869b812d-b22d-49ed-9d86-c30e4a014a9d",
"labels": [
{
"setId": "e7695a21-abb6-47ac-93f8-0ece5a9c4409",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e7695a21-abb6-47ac-93f8-0ece5a9c4409",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e7695a21-abb6-47ac-93f8-0ece5a9c4409"
}
],
"routes": [
"INTRAVENOUS"
],
"labeler": "Astellas Pharma US, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 VIAL in 1 BOX (0469-3425-10) / 5 mL in 1 VIAL",
"package_ndc": "0469-3425-10",
"identifierStatus": "well-formed",
"marketing_start_date": "20241024"
}
],
"productId": "0469-3425_869b812d-b22d-49ed-9d86-c30e4a014a9d",
"useDomain": "unknown",
"dosageForm": "INJECTION, POWDER, FOR SUSPENSION",
"productNdc": "0469-3425",
"deaSchedule": null,
"genericName": "ZOLBETUXIMAB",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "ZOLBETUXIMAB",
"strength": "20 mg/mL"
}
],
"applicationNumber": "BLA761365",
"marketingCategory": "BLA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20241024",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000194107",
"N0000194106"
],
"unii": [
"TF5MPQ8WGY"
],
"rxcui": [
"2695876",
"2695882",
"2710430",
"2710432"
],
"spl_set_id": [
"e7695a21-abb6-47ac-93f8-0ece5a9c4409"
],
"pharm_class_epc": [
"Claudin 18.2-directed Cytolytic Antibody [EPC]"
],
"pharm_class_moa": [
"Claudin 18.2-directed Antibody Interactions [MoA]"
],
"manufacturer_name": [
"Astellas Pharma US, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:0469-3425_869b812d-b22d-49ed-9d86-c30e4a014a9d"